[artículo] 
inThe Journal of Clinical Psychiatry > Año 2011 - Vol.72 - No. 12 (Diciembre) . - pp. 1616-1627

Título :	Mid term and long term efficacy and effectiveness of antipsychotic medications for schizophrenia : a data driven, personalized clinical approach
Tipo de documento:	texto impreso
Autores:	Ira D. Glick, Autor ; Christoph U. Correll, Autor ; A. Carlo Altamura, Autor
Fecha de publicación:	2022
Artículo en la página:	pp. 1616-1627
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Antipsicóticos, Benzodiacepinas, Clozapina, Terapia de modalidad combinada, Psicoterapia, Trastornos psicóticos, Risperidona, Esquizofrenia.
Resumen:	Our aim in this article is 2-fold: first, to examine the mid-term to long-term data on efficacy, from controlled and naturalistic and other studies, in order to determine if they are consistent with the quantitative meta-analyses of mostly short-term, randomized controlled trials Our second (and most important) aim is to use these and other data to provide guidance about the potential relationship of these differences among antipsychotics to the individual patient's own experience with antipsychotic drugs in the process of shared decision-making with the patients and their significant others.
Link:	./index.php?lvl=notice_display&id=28115

[artículo] Mid term and long term efficacy and effectiveness of antipsychotic medications for schizophrenia : a data driven, personalized clinical approach [texto impreso] / Ira D. Glick, Autor ; Christoph U. Correll, Autor ; A. Carlo Altamura, Autor . - 2022 . - pp. 1616-1627.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2011 - Vol.72 - No. 12 (Diciembre) . - pp. 1616-1627

Palabras clave:	Antipsicóticos, Benzodiacepinas, Clozapina, Terapia de modalidad combinada, Psicoterapia, Trastornos psicóticos, Risperidona, Esquizofrenia.
Resumen:	Our aim in this article is 2-fold: first, to examine the mid-term to long-term data on efficacy, from controlled and naturalistic and other studies, in order to determine if they are consistent with the quantitative meta-analyses of mostly short-term, randomized controlled trials Our second (and most important) aim is to use these and other data to provide guidance about the potential relationship of these differences among antipsychotics to the individual patient's own experience with antipsychotic drugs in the process of shared decision-making with the patients and their significant others.
Link:	./index.php?lvl=notice_display&id=28115